Abstract
Background
Cardiac involvement in sarcoidosis has been associated with poor prognosis. We evaluated myocardial contractility quantitatively in a cohort of pulmonary sarcoidosis (PS) patients with and without cardiac involvement. We also studied markers of fibrosis (tenascin-C [Tn-C] and galectin-3 [Gl-3]) as diagnostic tools for PS and cardiac sarcoidosis (CS).
Methods
Forty ambulatory patients with PS of grades 1–2 and 26 healthy subjects were prospectively enrolled. All patients with PS underwent cardiac magnetic resonance (CMR) to explore the presence of CS. The study population was divided into three groups: controls (n = 26), non-CS patients (n = 34), and CS patients (n = 6). Speckle-tracking strain echocardiography (STE) was performed on all patients, and Gl-3 and Tn-C values were measured in all patients and controls.
Results
PS patients had higher levels of Gl-3 and Tn-C than did controls, and the STE parameters of PS patients, including global longitudinal strain (GLS) and global circumferential strain (GCS), were lower than those of controls (p < 0.001 for all comparisons). GLS values were lower in CS patients than in the other groups (p = 0.05).
Conclusions
PS patients demonstrate reduced cardiac contractility, independent of CMR-proven structural cardiac lesions, while patients with structural lesions have a more pronounced drop in strain parameters. Tn-C and Gl-3 are promising markers for the diagnosis of PS, but they are not specific for cardiac involvement.
Similar content being viewed by others
References
Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr, Prystowsky EN, Prystowsky S (2009) Cardiac sarcoidosis. Am Heart J 157(1):9–21
Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336(17):1224–1234
Iwai K, Tachibana T, Takemura T (1993) Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn 43:372–376
Sekhri V, Sanal S, Delorenzo LJ, Aronow WS, Maguire GP (2011) Cardiac sarcoidosis: a comprehensive review. Arch Med Sci 7(4):546–554
Shimoni S, Gendelman G, Ayzenberg O, Smirin N, Lysyansky P, Edri O, Deutsch L, Caspi A, Friedman Z (2011) Differential effects of coronary artery stenosis on myocardial function: the value of myocardial strain analysis for the detection of coronary artery disease. J Am Soc Echocardiogr 24:748–757
Petersen JW, Nazir TF, Lee L, Garvan CS, Karimi A (2013) Speckle tracking echocardiography-determined measures of global and regional left ventricular function correlate with functional capacity in patients with and without preserved ejection fraction. Cardiovasc Ultrasound 11:20. doi:10.1186/1476-7120-11-20
Galderisi M, Esposito R, Schiano-Lomoriello V, Santoro A, Ippolito R, Schiattarella P, Strazzullo P, de Simone G (2012) Correlates of global area strain in native hypertensive patients: a three-dimensional speckle-tracking echocardiography study. Eur Heart J Cardiovasc Imaging 13(9):730–738
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias (2002) This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:277–304
Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP (1999) ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16:149–173
Prasse A, Katic C, Germann M, Buchwald A, Zissel G, Müller-Quernheim J (2008) Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med 177(3):330–336
Soejima K, Yada H (2009) The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 20:578
Cerqueira MD, Weissman NJ, Dilsizian V, Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; AHA Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542
Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, Crijns HJ (2005) Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45(10):1683–1690
Vignaux O, Dhote R, Duboc D, Blanche P, Dusser D, Weber S, Legmann P (2002) Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 122:1895–1901
Hunninghake GW, Garrett KC, Richerson HB, Fantone JC, Ward PA, Rennard SI, Bitterman PB, Crystal RG (1984) Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis 130(3):476–496
Lok DJ, Van Der Meer P, de la Porte PW, Lipsic E, Van Wijngaarden J, Hillege HL, van Veldhuisen DJ (2010) Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol 99(5):323–328
Cullinane AR, Yeager C, Dorward H, Carmona-Rivera C, Wu HP, Moss J, O’Brien KJ, Nathan SD, Meyer KC, Rosas IO, Helip-Wooley A, Huizing M, Gahl WA, Gochuico BR (2014) Dysregulation of galectin-3: Implications for Hermansky-Pudlak Syndrome pulmonary fibrosis. Am J Respir Cell Mol Biol 50(3):605–613
van der Velde AR, Gullestad L, Ueland T, Aukrust P, Guo Y, Adourian A, Muntendam P, van Veldhuisen DJ, de Boer RA (2013) Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH. Circ Heart Fail 6(2):219–226
Golledge J, Clancy P, Maguire J, Lincz L, Koblar S (2011) The role of tenascin C in cardiovascular disease. Cardiovasc Res 92(1):19–28
Niebroj-Dobosz I (2012) Tenascin-C in human cardiac pathology. Clin Chim Acta 413(19–20):1516–1518
Fujita H, Sakamoto N, Ishimatsu Y, Kakugawa T, Nakashima S, Hara S, Hara A, Mukae H, Kohno S (2012) Elevated tenascin-C levels in bronchoalveolar lavage fluid of patients with sarcoidosis. Lung 190(5):537–543
Greulich S, Deluigi CC, Gloekler S, Wahl A, Zürn C, Kramer U, Nothnagel D, Bültel H, Schumm J, Grün S, Ong P, Wagner A, Schneider S, Nassenstein K, Gawaz M, Sechtem U, Bruder O, Mahrholdt H (2013) CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 6(4):501–511
Mehta D, Lubitz SA, Frankel Z, Wisnivesky JP, Einstein AJ, Goldman M, Machac J, Teirstein A (2008) Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 133(6):1426–1435
Watanabe E, Kimura F, Nakajima T, Hiroe M, Kasai Y, Nagata M, Kawana M, Hagiwara N (2013) Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function. J Thorac Imaging 28(1):60–66
Suzuki T, Kanda T, Kubota S, Imai S, Murata K (1994) Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest 106(4):1021–1024
Aydin Kaderli A, Gullulu S, Coskun F, Yilmaz D, Uzaslan E (2010) Impaired left ventricular systolic and diastolic functions in patients with early grade pulmonary sarcoidosis. Eur J Echocardiogr 11(10):809–813
Rapti A, Kouranos V, Gialafos E, Aggeli K, Moyssakis J, Kallianos A, Kostopoulos C, Anagnostopoulou O, Sfikakis PP, Wells AU, Tzelepis GE (2013) Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors. Lung 191(1):61–67
Moyssakis I, Gialafos E, Tentolouris N, Floudas CS, Papaioannou TG, Kostopoulos C, Latsi P, Vaiopoulos G, Votteas V, Rapti A (2008) Impaired aortic elastic properties in patients with systemic sarcoidosis. Eur J Clin Invest 38(2):82–89
Shah BN, De Villa M, Khattar RS, Senior R (2013) Imaging cardiac sarcoidosis: the incremental benefit of speckle tracking echocardiography. Echocardiography 30(7):E213–E214. doi:10.1111/echo.12208
Tsuji T, Tanaka H, Matsumoto K, Miyoshi T, Hiraishi M, Kaneko A, Ryo K, Fukuda Y, Tatsumi K, Onishi T, Kawai H, Hirata KI (2013) Capability of three-dimensional speckle tracking radial strain for identification of patients with cardiac sarcoidosis. Int J Cardiovasc Imaging 29(2):317–324
Kansal MM, Panse PM, Abe H, Caracciolo G, Wilansky S, Tajik AJ, Khandheria BK, Sengupta PP (2012) Relationship of contrast-enhanced magnetic resonance imaging-derived intramural scar distribution and speckle tracking echocardiography-derived left ventricular two-dimensional strains. Eur Heart J Cardiovasc Imaging 13(2):152–158
Aggeli C, Felekos I, Tousoulis D, Gialafos E, Rapti A, Stefanadis C (2013) Myocardial mechanics for the early detection of cardiac sarcoidosis. Int J Cardiol 168(5):4820–4821. doi:10.1016/j.ijcard.2013.07.010
Date T, Shinozaki T, Yamakawa M, Taniguchi I, Suda A, Hara H, Yamane T, Komukai K, Sugimoto K, Mochizuki S (2007) Elevated plasma brain natriuretic peptide level in cardiac sarcoidosis patients with preserved ejection fraction. Cardiology 107(4):277–280
Magrì D, Agostoni P, Ricotta A, Pisani L, Cauti FM, Onofri A, Bruno P, Ricci A, Volpe M, Marchitti S, Mariotta S, Rubattu S (2013) NT-proatrial natriuretic peptide as a possible biomarker of cardiopulmonary involvement in sarcoidosis. Eur J Intern Med 24:278–284
Acknowledgments
This study was funded by the Scientific Research Project Support Unit of Bezmialem Vakif University.
Conflict of interest
The authors have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kul, S., Ozcelik, H.K., Uyarel, H. et al. Diagnostic Value of Strain Echocardiography, Galectin-3, and Tenascin-C Levels for the Identification of Patients with Pulmonary and Cardiac Sarcoidosis. Lung 192, 533–542 (2014). https://doi.org/10.1007/s00408-014-9586-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-014-9586-5